ClearPoint Neuro, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders' Equity (Tables)

Note 7 - Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2015

Assumptions Used in Calculating Fair Value of Warrants Issued [Table Text Block]

Dividend yield		0%
Expected Volatility	47.5%	-	47.7%
Risk free Interest rates	1.73%	-	1.76%
Expected life (in years)		5.0

Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]

Fair value at December 31, 2014	$	2,198,162
Loss on change in fair value		782,802
Fair value at March 31, 2015	$	2,980,964

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Shares			Weighted - Average Exercise Price
Outstanding at December 31, 2014		10,343,309		$	1.36
Granted		502,500			1.01
Forfeited		(35,000	)		0.99
Outstanding at March 31, 2015		10,810,809			1.35

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Dividend yield		0%
Expected Volatility	46.7%	to	48.8%
Risk free Interest rates	1.95%	to	2.71%
Expected lives (in years)		6.0

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

Three Months Ended March 31,
2015		2014
$	367,309	$	179,746

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

	Shares			Weighted - Average Exercise Price
Outstanding at December 31, 2014		20,759,136		$	0.91
Issued		35,000			1.00
Terminated		(25,444	)		8.00
Outstanding at March 31, 2015		20,768,692			0.90

Common Stock Warrants Issued in Private Placement [Member]

Notes Tables

Assumptions Used in Calculating Fair Value of Warrants Issued [Table Text Block]

Dividend yield		0%
Expected volatility	40.4%	-	100.0%
Risk free interest rates	0.56%	-	0.70%
Expected remaining term (in years)	2.26	-	2.82

- Definition

Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.

+ References + Details

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details